Topic: Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergi

Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.

http://www.ncbi.nlm.nih.gov/pubmed/23588885

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.

Re: Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergi

thanks so much Gavin - very intyeresting!

Re: Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergi

Glad to be of help rain!

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.